House lawmakers have postponed a Tuesday hearing to question former pharmaceutical CEO Martin Shkreli, reviled for hiking the price of a lifesaving drug, due to the blizzard over the weekend.
The House Committee on Oversight and Government Reform plans to reschedule the hearing on exorbitant drug price increases by Shkreli’s former company, Turing Pharmaceuticals, and other drugmakers.
The delay increases the likelihood that Shkreli will attend.
Lawmakers subpoenaed Shkreli earlier this month. But last week his lawyer requested he be excused from attending the hearing, since his terms of bail forbid him from leaving New York. The case involves a previous company he founded before Turing.
The Department of Justice requested Sunday that a New York judge allow Shkreli to travel to Washington, according to a legal filing.
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
